Clinical Trials Browser

Interventional × Triple Negative Breast Neoplasms × ostarine × Clear all

NCT02971761 2024-02-20

Pembrolizumab and Enobosarm in Treating Patients With Androgen Receptor Positive Metastatic Triple Negative Breast Cancer

Phase 2 Completed

18 enrolled 17 charts

Triple Negative Breast Neoplasms

NCT02368691 2020-11-18

Efficacy and Safety of GTx-024 in Patients With Androgen Receptor-Positive Triple Negative Breast Cancer (AR+ TNBC)

Phase 2 Terminated

32 enrolled 12 charts

Triple Negative Breast Neoplasms